Navigating adulthood: Exploring the transition needs of adolescents and young adults affected by Duchenne or Becker muscular dystrophy

Navigating adulthood: Exploring the transition needs of adolescents and young adults affected by Duchenne or Becker muscular dystrophy

Saved in:

Bibliographic Details
Main Authors:	Sharon Barak, Shirley Ackerman Laufer, Michal Gudinsky Elyashiv, Sharon Rubinstein-Shatz, Rama Davidson, Tali Kaplan
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2025-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11731756/?tool=EBI
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Optimizing Bone Health in Duchenne Muscular Dystrophy
by: Jason L. Buckner, et al.
Published: (2015-01-01)

Label-free proteomic analysis of Duchenne and Becker muscular dystrophy showed decreased sarcomere proteins and increased ubiquitination-related proteins
by: Juliana Cristina Tobar da Silva, et al.
Published: (2025-01-01)

Facioscapulohumeral muscular dystrophy type 1 combined with becker muscular dystrophy: a family case report
by: Menglin Tan, et al.
Published: (2025-01-01)

Prenatal Diagnosis of the Duchenne Muscular Dystrophy. A Family Presentation
by: Humberto Perera Navarro, et al.
Published: (2007-05-01)

Duchenne muscular dystrophy: recent insights in brain related comorbidities
by: Cyrille Vaillend, et al.
Published: (2025-02-01)

Sugammadex and Reversal of Neuromuscular Block in Adult Patient with Duchenne Muscular Dystrophy
by: Ahmed Abdelgawwad Wefki Abdelgawwad Shousha, et al.
Published: (2014-01-01)

Unraveling the Genetic Heartbeat: Decoding Cardiac Involvement in Duchenne Muscular Dystrophy
by: Valeria Novelli, et al.
Published: (2025-01-01)

Bone measurements interact with phenotypic measures in canine Duchenne muscular dystrophy
by: Sarah M. Schneider, et al.
Published: (2025-01-01)

A manifesting female carrier of Duchenne muscular dystrophy: importance of genetics for the dystrophinopathies
by: Zhi Xuan Quak, et al.
Published: (2023-01-01)

Impact of distinct dystrophin gene mutations on behavioral phenotypes of Duchenne muscular dystrophy
by: Amel Saoudi, et al.
Published: (2024-12-01)

Cytokines and Chemokines as Regulators of Skeletal Muscle Inflammation: Presenting the Case of Duchenne Muscular Dystrophy
by: Boel De Paepe, et al.
Published: (2013-01-01)

Review of upper extremity passive joint impedance identification in people with Duchenne Muscular Dystrophy
by: Suzanne J. Filius, et al.
Published: (2025-01-01)

Growth Hormone Deficiency in a Patient with Becker Muscular Dystrophy: A Pediatric Case Report
by: Valeria Calcaterra, et al.
Published: (2013-01-01)

Respiratory pathology in the mdx/utrn -/- mouse: A murine model for Duchenne Muscular Dystrophy (DMD).
by: Marán Y Hernández Rodríguez, et al.
Published: (2025-01-01)

Advances in Nucleic Acid Drugs and Gene Therapies based on Animal Models of Duchenne Muscular Dystrophy
by: LIU Siyu, et al.
Published: (2024-12-01)

Dilated cardiomyopathy in a patient with newly diagnosed Becker muscular dystrophy: more than meets the eye
by: Marie Houdmount, et al.
Published: (2023-06-01)

A structural genomics approach to investigate Dystrophin mutations and their impact on the molecular pathways of Duchenne muscular dystrophy
by: Abdelbaset Mohamed Elasbali, et al.
Published: (2025-02-01)

Diagnóstico molecular de distrofia muscular de Duchenne/Becker en una familia sin antecedentes patológicos de la enfermedad
by: Ivonne Martín Hernández, et al.
Published: (2018-10-01)

Quantitative Structure–Property Relationship Modeling with the Prediction of Physicochemical Properties of Some Novel Duchenne Muscular Dystrophy Drugs
by: Jyothish K, et al.
Published: (2025-01-01)

Pharmacological interventions for the management of anesthesia and sedation in patients with Duchenne muscular dystrophy: a systematic review and meta-analysis
by: Xianghong Lian, et al.
Published: (2025-01-01)

Cellular Reprogramming, Genome Editing, and Alternative CRISPR Cas9 Technologies for Precise Gene Therapy of Duchenne Muscular Dystrophy
by: Peter Gee, et al.
Published: (2017-01-01)

Gestational Outcomes of Pregnant Women Who Have Had Invasive Prenatal Testing for the Prenatal Diagnosis of Duchenne Muscular Dystrophy
by: Mehmet Sinan Beksac, et al.
Published: (2018-01-01)

Height development and multiple bone health indicators in children aged 2-12 years with Duchenne muscular dystrophy (DMD).
by: Bingying Wang, et al.
Published: (2025-01-01)

The hidden face of Duchenne (Neuro)Muscular Dystrophy. Preliminary evidence of social cognition impairment as a feature of the neuropsychological phenotype of DMD
by: S. Parravicini, et al.
Published: (2025-01-01)

Histone deacetylase inhibition with givinostat: a multi-targeted mode of action with the potential to halt the pathological cascade of Duchenne muscular dystrophy
by: A. Aartsma-Rus
Published: (2025-01-01)

Skeletal muscle stem cells modulate niche function in Duchenne muscular dystrophy mouse through YY1-CCL5 axis
by: Yang Li, et al.
Published: (2025-02-01)

Brain glucose metabolism as a neuronal substrate of the abnormal behavioral response to stress in the mdx mouse, a model of Duchenne muscular dystrophy
by: Sébastien Goutal, et al.
Published: (2025-01-01)

Caregiver Global Impression Observations from EMBARK: A Phase 3 Study Evaluating Delandistrogene Moxeparvovec in Ambulatory Patients with Duchenne Muscular Dystrophy
by: Craig M. McDonald, et al.
Published: (2024-11-01)

Proteoglycans are Differentially Altered in Muscular Dystrophies
by: Simona Zanotti, et al.
Published: (2006-01-01)

Beta-hydroxy-beta-methylbutyrate (HMB) improves daily activity and whole-body protein metabolism in Duchenne muscular dystrophy dogs: a pilot study
by: Peter P. Nghiem, et al.
Published: (2025-02-01)

Aminoguanidine hemisulfate improves mitochondrial autophagy, oxidative stress, and muscle force in Duchenne muscular dystrophy via the AKT/FOXO1 pathway in mdx mice
by: Shiyue Sun, et al.
Published: (2025-01-01)

Titin fragment is a sensitive biomarker in Duchenne muscular dystrophy model mice carrying full-length human dystrophin gene on human artificial chromosome
by: Yosuke Hiramuki, et al.
Published: (2025-01-01)

Elderly Onset of Weakness in Facioscapulohumeral Muscular Dystrophy
by: Dominic B. Fee
Published: (2012-01-01)

Satellite Cells: Regenerative Mechanisms and Applicability in Muscular Dystrophy
by: Gustavo Torres de Souza, et al.
Published: (2015-01-01)

Echocardiographic Features of Cardiomyopathy in Emery-Dreifuss Muscular Dystrophy
by: Michał Marchel, et al.
Published: (2021-01-01)

Muscular Dystrophies at Different Ages: Metabolic and Endocrine Alterations
by: Oriana del Rocío Cruz Guzmán, et al.
Published: (2012-01-01)

Congenital muscular dystrophies and myopathies: the leading cause of genetic muscular disorders in eleven Chinese families
by: Bin Mao, et al.
Published: (2025-01-01)

Facioscapulohumeral muscular dystrophy: a review of pathogenesis, clinical symptoms, and treatment
by: T. Mikalauskas, et al.
Published: (2023-10-01)

Elevated Aminotransferase Activity as an Indication of Muscular Dystrophy: Case Reports and Review of the Literature
by: S Zamora, et al.
Published: (1996-01-01)

Howard S. Becker - Kanıt
by: Engin Durukan Abdulhakimoğulları
Published: (2022-04-01)